ReviewFrontiers in pharmacology2026
Platinum cross-resistance after first-line PARPi maintenance in ovarian cancer: a review and proposed redefinition of platinum resistance.
Rong Mei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.